<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119453">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02049970</url>
  </required_header>
  <id_info>
    <org_study_id>2013/107</org_study_id>
    <nct_id>NCT02049970</nct_id>
  </id_info>
  <brief_title>Effect of the Addition of Dexmedetomidine to Bupivacaine During Supraclavicular Brachial Plexus Blockade</brief_title>
  <official_title>Effect of the Addition of Dexmedetomidine to Bupivacaine During Supraclavicular Brachial Plexus Blockade for Forearm Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      the aim of this study was effect of the addition of dexmedetomidine to bupivacaine during
      supraclavicular brachial plexus blockade for forearm surgery, by low doses bupivacaine
      providing prolonged analgesia after surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anaesthesia for surgeries to the upper extremity commonly is provided using brachial plexus
      anaesthesia.Various local anaesthetic mixtures can be used to prolong local anaesthesia
      duration and epinephrine , opioids and dexmedetomidine are frequently used for this purpose.
      this study  was conducted to compare the effects of adding dexmedetomidine to local
      anaesthetics in the supraclavicular brachial plexus block by using nerve stimulators and
      ultrasonography guided. dexmedetomidine has also been found the prolong the duration of
      bupivacaine  infraclavicular brachial plexus block.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>the duration of sensorial block</measure>
    <time_frame>postoperative 1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>pin-prick test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the first time analgesic required</measure>
    <time_frame>postoperative 1 day</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sequelae of Fracture of Forearm and Upper Arm</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine and bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bupivacaine 50 mg and dexmedetomidine 1 microgram/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine and placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bupivacaine 100 mg and SF 10 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine</intervention_name>
    <arm_group_label>dexmedetomidine and bupivacaine</arm_group_label>
    <arm_group_label>Bupivacaine and placebo</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine</intervention_name>
    <description>Bupivacaine and placebo</description>
    <arm_group_label>dexmedetomidine and bupivacaine</arm_group_label>
    <arm_group_label>Bupivacaine and placebo</arm_group_label>
    <other_name>marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 age

          -  unwanted general anaesthesia

          -  ASA 1-2

          -  single forearm, arm  surgery

        Exclusion Criteria:

          -  major psychiatric problems

          -  major neurologic deficits

          -  coagulopathy

          -  drug allergies

          -  chronic analgesic used
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Recep Aksu</last_name>
    <role>Study Director</role>
    <affiliation>Ass.Prof.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Recep AKSU, ass. prof.</last_name>
    <phone>+903522076666</phone>
    <phone_ext>24035</phone_ext>
    <email>raksu@erciyes.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cihangir BİÇER, ass. prof.</last_name>
    <phone>+903522076666</phone>
    <phone_ext>24033</phone_ext>
    <email>cbicer33@yahoo.com.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erciyes University Medical Faculty</name>
      <address>
        <city>Kayseri</city>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Recep Aksu</last_name>
      <phone>00903522076666</phone>
      <email>raksu@erciyes.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 31, 2014</lastchanged_date>
  <firstreceived_date>January 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>Recep Aksu</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>Supraclavicular block</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
